EpiVax Awarded Grant For Vaccine Engineering

EpiVax Awarded Grant For Vaccine Engineering

$5.8 MILLION AWARDED FOR VACCINE ENGINEERING WILL USE “IMMUNE HISTORY” TO PROTECT AGAINST BIRD FLU, A COLLABORATION LED BY EPIVAX   PROVIDENCE, R.I., Sept. 18, 2017– EpiVax, Inc. (“EpiVax”) a pioneer in the fields of bioinformatics and immune engineering, today...

Why Stockpile Ineffective Vaccines?

Let’s Make Vaccines and Stockpile Them . . . Not! How about this for great business model – selling vaccines that are put on a shelf and have to be replaced every 4 years. Some vaccine companies make billions on that proposition. But we ask, as citizens...